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ABSTRACT: A copper complex embedded in the
structure of a water-soluble naphthalene diimide has
been designed to bind and cleave G-quadruplex DNA. We
describe the properties of this ligand, including its
catalytic activity in the generation of ROS. FRET melting,
CD, NMR, gel sequencing, and mass spectrometry
experiments highlight a unique and unexpected selectivity
in cleaving G-quadruplex sequences. This selectivity relies
both on the binding aﬃnity and structural features of the
targeted G-quadruplexes.
Nucleic acid sequences rich in guanine (G) base are ableto fold into G-quadruplex (G4) structures in the
presence of suitable alkali metals (K+ or Na+). G4s are
characterized by square-planar conﬁgurations of four Gs,
arranged through Hoogsteen hydrogen bonding, and they
diﬀer from each other by chain number and orientation.1−3
These supramolecular structures have received increasing
attention as they are involved in genomic instability,1,4
telomerase dysfunction,5,6 regulation of gene expression,7,8
and viral transcription.9,10 In particular, these structures have
been shown to have regulatory functions for telomere
extension and maintenance,11 thus playing important roles in
cancer biology.12−14 In addition, G4s involved in the life cycle
of diﬀerent viruses, such as HIV-1,15−18 HSV-1,19 EBV,20,21
HCV, and others,22 have been reported. Consequently, small
molecules that target, stabilize, and also modify G4s represent
potential anticancer agents23,24 and antiviral drugs.25,26 To
date, a large number of G4 ligands, including naphthalene
diimides (NDIs), have been published, but the selective
cleavage of G4s has only been achieved once, on intra-
molecular telomeric G4s.27 Thus, far, none of the investigated
DNA-cleavers can target nontelomeric G4s, nor any selective
scissoring, discriminating a G4 among others, has been
reported yet. Among the transition metals that participate in
various metabolic processes in living organisms, copper is one
of the essential enzyme cofactors owing to its redox properties.
This has inspired a catalytic metallo-drug strategy in nucleic
acid chemistry.27 In fact, Cu ligands were found to be active in
vitro28 and in vivo via metal-mediated DNA cleavage through
reactive oxygen species (ROS).7,27,29−32 In our previous study,
we developed core-substituted NDIs able to coordinate with
low aﬃnity (K−d = 2.0 × 10
5 M−1) Cu(II) in close proximity to
the aromatic core.33 Much higher aﬃnity (K−d > 10
16 M−1) is
required to generate ROS in the presence of nucleic acids to
avoid Cu(II) translocation. In this study, we merged both the
Cu and G4 binding features in a NDI−Cu complex, containing
a diethylenetriamine (DETA) substituent (NDI−Cu−DETA,
Figure 1), which eﬀectively and selectively chelates Cu2+ at
physiological pH (Figure S1−S3, Table S1). The high-aﬃnity
constant for Cu2+(K−d = 1.99 × 10
17 M−1) has been measured
by titration with Tren as competing ligand (Figure S4−S6).34
Substituted NDIs are well-known reversible ligands, binding
G4s by end-stacking interactions with high aﬃnity.35−38 To
determine whether the addition of the Cu moiety aﬀected G4-
selectivity, NDI-Cu-DETA and its NDI Cu-free precursor
(NDI−DETA) were tested on both cellular and viral G4
oligonucleotides and dsDNA (Table S2) by FRET melting
Received: May 22, 2018
Published: October 14, 2018
Figure 1. Structures and NDI-Cu-DETA (50 μM) titration by Tren:
(a) absorption spectra and (b) distribution diagram.
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studies at diﬀerent K+ concentrations (Table S3 and Figure
S23A). While the introduction of Cu slightly destabilized the
G4s (ΔTm on average 18% lower than with NDI−DETA),
NDI−Cu−DETA retained G4 selectivity. ΔTm were inversely
dependent on the stability of the G4 oligonucleotide itself
(ΔTm increased at lower K+ concentration and was not
measurable in c-myc and bcl-2, which displayed the highest
intrinsic Tm). G4/NDI−Cu−DETA complex stability was also
assessed by thermal denaturation analysis monitored by CD
(Figure S23B). To give a meaningful comparison, the K+
amount was modulated so that initial Tm values of all tested
G4s were maintained in the 50−60 °C range (Table S4). ΔTm
values above 22 °C were observed for mammalian hTel22, c-
myc, bcl-2, and c-kit2 and for HIV-1 LTR-III+IV and LTR-IV
and HSV-1 gp054b (Table S4). No conformation dependence
was noted. Under physiological conditions (50 mM phosphate
buﬀer pH 7.4), NDI−Cu−DETA exhibited catalytic activity
for ROS generation, causing the oxidation of an external
substrate such as 4-tertbutylcatechol (Figure S7). To mimic the
reducing intracellular environment, as a useful model reaction
for ROS generation, we took advantage of the Cu(I)-catalyzed
reduction of hydrogen peroxide in the presence of ascorbate,
which yields hydroxyl radicals.39 To conﬁrm the involvement
of diﬀusible hydroxyl radicals under the catalytic conditions
used, we monitored at 440 nm, in 50 mM phosphate buﬀer
(pH 7.4, 37 °C; Figure S8), the eﬀective bleaching of p-
nitrosodimethylaniline (p-NDA).40,41 Ligand interaction with
G4s drove the reactivity onto the DNA, making its oxidation a
competitive process with the p-NDA and erasing its bleaching
(Figure S8).
NDI−Cu−DETA was evaluated as a speciﬁc G4 DNA
cleaver in the presence of ascorbic acid and hydrogen peroxide
for 2.5−5 min at 25 °C. The complex was initially reacted with
a G4-folded telomeric sequence (i.e., hTel22), a scrambled
sequence unable to fold into G4 (ss scr hTel22) and its
dsDNA (ds scr hTel22, Table S2). The resulting reaction
mixtures were analyzed by denaturing polyacrylamide gel
electrophoresis. Major cleavage sites were observed in the
presence of NDI−Cu−DETA on hTel22 at bases G4, A7−G9,
A13−G15, and A19−G21 (Figure 2A). In contrast, much
weaker and unspeciﬁc cleavage sites were present in the
control mutant ss and dsDNAs. Cleavage reactivity of NDI−
Cu−DETA was next investigated on a panel of structurally and
topologically diﬀerent G4s, i.e., LTR-III and LTR-IV found in
HIV-1, un2, gp054b, and gp054e found in HSV-1, c-myc, bcl-
2, c-kit1, and c-kit2 found in mammals (Table S2). The
cleavage eﬃciency, compared to the cleavage of the least
reactive ds scr hTel22, was 1.7 and 2.5 higher for ss scr hTel22
and hTel, respectively. All other G4s were cleaved at even
higher folds: 4x c-myc and bcl-2, 6× LTR-IV, 7.3× c-kit1, 7.4×
gp054b, 7.7× gp054e, 8.2× LTR-III, 9.5× un2, and 12.8 c-kit2
(Table S5).
Selectivity for single sites was considered when cleavage
bands corresponded to at least 20% of total cleavage. Site
selectivity was obtained on HIV-1 LTR-III (A4 27% and T14
20%), HSV-1 un2 (C13−-G15 30%) (Figure 2B), gp054b and
gp054e (T11 27% and C11 22%) (Figure 2C). In contrast,
LTR-IV (Figure 2C), c-myc and bcl-2 (Figure S11A), and c-
kit1 and c-kit2 (Figure S11B) revealed multisite reactivity
(Table S5). Very interestingly, the two HSV-1 sequences
gp054b and gp054e, which diﬀer by only one nucleotide in two
loops (Table S2), exhibited the exact same reactivity on the
one diﬀerent nucleotide in one of the loops (Figure 2C). Also
in the case of these G4-folded oligonucleotides, cleavage was
more eﬃcient and site-selective toward the G4s vs mutated ss
and dsDNAs derived from the tested oligonucleotides (Figure
S9 and Table S2). To further conﬁrm G4 selectivity, excess of
the mutated dsDNAs was used in a competition cleavage assay
in the presence of NDI−Cu−DETA (Figure S10). The ds
competitors did not signiﬁcantly alter the cleavage of the
corresponding G4 oligonucleotides when used at 2-fold excess:
the relative cleavage was reduced by 12% in LTR-III and 4% in
un2 and was not reduced in gp054b. Only at 4-folds, the
competitors inhibited site-selective cleavage on the G4s. G4
site-selectivity may be the result of NDI−Cu−DETA-mediated
“on-target” hydroxyl radical generation compared to in
Figure 2. NDI−Cu−DETA-induced cleavage of G4-folded sequences: (A) G4-folded telomeric sequence (hTel22), a scrambled sequence unable
to fold into G4 (ss scr hTel22, same base composition and diﬀerent sequence) and its dsDNA (ds scr hTel22, Table S2); (B) LTR-III and un2;
(C) LTR-IV, gp054b and gp054e. Oligonucleotides (0.25 μM) reacted with NDI−Cu−DETA (A) 25 μM, (B and C) 3.12 μM) for 2.5 or 5 min
(lanes 4 and 5, respectively) in the presence of 1 mM sodium ascorbate and 1 mM hydrogen peroxide, as indicated. Samples were run on
denaturing polyacrylamide gels. Asterisks highlight major cleavage sites, M = marker lane. Panels include intensity proﬁles of lanes 4 and
quantiﬁcation of the major bands (%).
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solution radical generation in the case of the unfolded ss and ds
oligonucleotides. This hypothesis is corroborated by cleavage
data reported for a copper−peptide complex conjugated to
acridine, where the ligand exhibited preferred binding to
hTel22 G4 over duplex DNA.27 This data also suggests a
structure- rather than sequence-dependent selectivity by the
NDI−Cu−DETA, which remains stable under the oxidative
conditions of the DNA cleavage studies (Figures S12 and S13).
To assess the extension of NDI−Cu−DETA reactivity
toward DNA bases, LTR-III G4 was treated with hot
piperidine, which stimulates phosphodiester bond cleavage at
reacted bases (Figure S14). Piperidine increased band intensity
both at the main sites of NDI−Cu−DETA-induced cleavage
and at other sites (∗ and §, respectively, in Figure S14),
indicating that base damage without cleavage occurred to a
lesser extent at other bases too. At longer reaction times,
NDI−Cu−DETA was able to induce cleavage also in the
absence of H2O2 (Figure S15), suggesting the possibility of
exploiting this reaction without oxidative stress. Mannitol, a
speciﬁc hydroxyl radical scavenger,42 did not aﬀect the NDI−
Cu−DETA-induced cleavage (Figure S15) in the presence of
G4s. This evidence indicates site-speciﬁc generation of the
hydroxyl radical without eﬀective oﬀ-target diﬀusion.
To clarify the cleavage mechanism, one of the most intense
cleavage sites in LTR-III G4 (C13 + T14 bands) was excised
from the polyacrylamide gel and analyzed by MS (Figure 3).
MS and MS/MS characterization43 of the products indicated
the presence of several fragments of similar mass, i.e.,
pG1:C13p, pG1:T14p, pC13:G28p, pT14:G28p), which
showed that NDI−Cu−DETA cut LTR-III predominantly at
the 3′ side of T14 and to a lesser extent C13 (Figure S16).
Detection of pG1:T14p (3′-phosphate and 3′-phosphoglyco-
late) and pG16:G28 (5′-phosphate) products indicated
reactivity of NDI−Cu−DETA at H1′ and H4′ of the ribose
moiety with consequent cleavage of the phosphate backbone,
degradation of G15 and release of pG1:T14p and
pG16:G28.44,45 In addition, oxidized G4s and guanosine
monophosphates (Figures S17 and S18, respectively) were
detected by MS upon S1 nuclease digestion. The presence of
oxidized bases in the absence of abasic cleavage products
(Figure 3) suggests that base oxidation is not the main
mechanism of DNA cleavage. These data are in line with the
additional cleavage at oxidized bases observed upon treatment
with piperidine (Figure S14). Therefore, H1′ and H4′
abstractions by the hydroxyl radical represent the main
mechanism of the G4 cleavage, in agreement with previously
reported mechanism of cleavage.27 To test if cleavage
speciﬁcity paralleled the aﬃnity of NDI−Cu−DETA toward
G4 oligonucleotides, binding aﬃnity was assessed by MS.
Oligonucleotides showing both site-speciﬁc (LTR-III, un2,
gp054b, gp054e) and multisite (LTR-IV, hTel22) cleavage
were considered. In a 1:1 complex stoichiometry, the highest
aﬃnity was observed for LTR-III, followed by un2. LTR-IV
and hTel22 showed intermediate aﬃnity, while the two HSV-1
G4s (gp054b and gp054e) were bound with the lowest
eﬃciency (Figure S19 and Table S6). These data suggest that
fraction-bound%46 is one of the driving forces toward site-
speciﬁc cleavage. However, other structural features, as in the
case of gp054b and gp054e, may control the cleavage site.
The nature of the NDI−Cu−DETA complexes with c-myc,
c-kit1, and LTR-III was investigated by one-dimensional 1H
NMR titration. Ligand binding to the G4 structures should
aﬀect the signals of DNA protons near the binding site. In fact,
for LTR-III, broadening upon addition of the compound was
observed for the peaks of the duplex stem (G5 and G6) and
one of the guanine in the top tetrad (G26) (Figure 4).47 These
data indicate a preference of the ligand to bind LTR-III at the
duplex−quadruplex junction. For c-myc and c-kit1 G4s, the
imino protons of the 5′-end G-tetrad were broadened ﬁrst,
followed by those of other guanines, indicating the preferential
binding of the compound at the 5′-end G-tetrad (Figure S20).
The preferred binding sites of the compound are consistent
with the major cutting sites observed by gel in both LTR-III
and c-myc (Figure 2B and Figure S11A, respectively). For c-
kit1, the cleavage data (Figure S11B) could be explained by a
coexistence of both the preferred biding site at the 5′-end G-
tetrad and an additional binding site near the bottom tetrad
or/and coexistence of an additional conformation (caption of
Figure S20).
To further support that site-speciﬁc generation of the
hydroxyl radical by NDI−Cu−DETA is the controlling factor
Figure 3. Spectra of the 5′-phosphate LTR-III cleavage band at C13 +
T14 extracted and analyzed by ESI-MS. The symbol ∗ represents the
oxidized peaks (exp. mass shift 15.99 amu). The symbol ¤ represents
the cleavage products with 3′-phosphoglycolate modiﬁcation (exptl
mass shift 57.99 amu). All peaks are labeled with the matching
sequence having the highest MS/MS coverage.
Figure 4. (A) 1H NMR spectra of LTR-III (100 μM), free and bound
to NDI−Cu−DETA at 1:1 ratio. The black arrows indicate imino
protons of G5, G6 from the duplex and G26 from the top tetrad,
which are preferentially broadened upon addition of the compound.
Buﬀer conditions: 70 mM KCl, 20 mM phosphate buﬀer, pH 7.0. (B)
Schematic of LTR-III G-quadruplex fold, cyan, magenta, and brown
indicate anti-guanine, syn-guanine, and cytosine residues, respectively.
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of the cleavage selectivity, we performed NDI−Cu−DETA
docking binding analysis on the LTR-III G4, whose structure
in solution has been elucidated by NMR studies.47 Docking
scoring analysis was performed in end-stacking and groove-
binding modes (Figure 5), with −9.3 and −8.5 kcal/mol
aﬃnity, respectively. In the end-stacking mode, NDI−Cu−
DETA binds only one end of the hybrid-G4 (Figure 5A),
placing the Cu binding cavity very close to the deoxyribose
moieties at both A4 and G5.
On the contrary, in the groove-binding mode, NDI−Cu−
DETA binds the LTR-III G4 (Figure 5B), placing the Cu
binding cavity nearby the deoxyribose moieties at C13 and
T14. The docking data are remarkably consistent with the
results of the above induced cleavage experiments (Figure 2B).
Both NMR-titration and docking data imply that the site-
preferred scission in LTR-III G4 by NDI−Cu−DETA vs c-
myc and c-kit1 G4s has to be ascribed to the extra-aﬃnity
conferred by the junction environment, as also suggested by
the MS aﬃnity data.
In conclusion, we have designed a novel naphthalene
diimide Cu(II) complex acting as G4-cleaving agent, which
targets selected G4 structures among others, with unexpected
site selectivity. Our new NDI−Cu−DETA is stable when
bound to a G4, producing hydroxyl radicals both in the
presence and absence of H2O2. In contrast to previously
published non site-selective cleavers,27 hydroxyl radicals are
produced in close proximity to the Cu coordination sphere: in
the case of HIV-1 LTR-III-G4 and other deﬁnite G4s, such as
un2 and gp054 found in HSV-1, hydroxyl radicals react on the
target, without diﬀusing in solution (Figure S8). The observed
site-selectivity relies on the NDI−Cu−DETA:G4 binding
geometry, which deﬁnes the proximity of the Cu catalytic site
to nearby regions (i.e., loops), independently of the target
sequence. Our compound represents the ﬁrst step toward the
development of eﬃcient cleavers for distinct G4s, to be used as
valuable tools for elucidating G4 formation and resolution.
Further improvement in their G4 vs dsDNA selectivity will be
sought for in vivo application, such as for the treatment of G4-
related diseases.
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